Cargando…
Routine HIV testing program in the University Infectious Diseases Centre in Lithuania: a four-year analysis
BACKGROUND: HIV transmission remains a major concern in Eastern Europe, and too many people are diagnosed late. Expanded testing strategies and early and appropriate access to care are required. Infectious disease departments might be targets for expanded HIV testing owing to the intense passage of...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322331/ https://www.ncbi.nlm.nih.gov/pubmed/30616558 http://dx.doi.org/10.1186/s12879-018-3661-0 |
_version_ | 1783385601230241792 |
---|---|
author | Matulionytė, Raimonda Žagminas, Kęstutis Balčiūnaitė, Eglė Matulytė, Elžbieta Paulauskienė, Rasutė Bajoriūnienė, Almina Ambrozaitis, Arvydas |
author_facet | Matulionytė, Raimonda Žagminas, Kęstutis Balčiūnaitė, Eglė Matulytė, Elžbieta Paulauskienė, Rasutė Bajoriūnienė, Almina Ambrozaitis, Arvydas |
author_sort | Matulionytė, Raimonda |
collection | PubMed |
description | BACKGROUND: HIV transmission remains a major concern in Eastern Europe, and too many people are diagnosed late. Expanded testing strategies and early and appropriate access to care are required. Infectious disease departments might be targets for expanded HIV testing owing to the intense passage of key patient populations that carry indicators of HIV disease. Our objective was to evaluate the feasibility and clinical effectiveness of a fully integrated, opt-out routine, rapid HIV testing program. METHODS: A retrospective four-year study of a screening program was conducted from 2010 through 2014. The program was divided into two periods: from 2010 to 2012 (pilot study) and from 2013 to 2014. The pilot study consisted of routine HIV testing of patients aged 18–55 that were hospitalized in one department. In the second period, all inpatients aged 18–65 were eligible. Targeted testing was conducted in the other inpatient department during the pilot study and the outpatient department during both periods. RESULTS: During the pilot study, 2203 patients were hospitalized, 1314 (59.6%) were eligible, 954 (72.6%) were tested, and 3 (0.31%) were newly diagnosed HIV-positive. In the second period, 4911 patients were hospitalized, 3727 (75.9%) were eligible, 3303 (88.6%) were tested, and 7 (0.21%) were HIV-positive. In total, 2800 targeted tests were performed, and 4 (0.14%) patients tested positive with newly discovered HIV. All 14 newly diagnosed patients were provided with care. Comparing cumulative groups of routine and targeted testing, the HIV prevalence was 0.23% vs. 0.14% (p = 0.40) and was above the reported cost-effectiveness threshold of 0.1% (p = 0.012). A lower proportion of advanced disease and a higher proportion of heterosexually transmitted infection were found in the routine testing group. CONCLUSION: Routine HIV testing in admissions of infectious diseases is acceptable, feasible, sustainable and clinically effective. Compared to targeted testing, routine testing helped to discover more patients in earlier stages and those with heterosexually transmitted HIV infection. |
format | Online Article Text |
id | pubmed-6322331 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-63223312019-01-10 Routine HIV testing program in the University Infectious Diseases Centre in Lithuania: a four-year analysis Matulionytė, Raimonda Žagminas, Kęstutis Balčiūnaitė, Eglė Matulytė, Elžbieta Paulauskienė, Rasutė Bajoriūnienė, Almina Ambrozaitis, Arvydas BMC Infect Dis Research Article BACKGROUND: HIV transmission remains a major concern in Eastern Europe, and too many people are diagnosed late. Expanded testing strategies and early and appropriate access to care are required. Infectious disease departments might be targets for expanded HIV testing owing to the intense passage of key patient populations that carry indicators of HIV disease. Our objective was to evaluate the feasibility and clinical effectiveness of a fully integrated, opt-out routine, rapid HIV testing program. METHODS: A retrospective four-year study of a screening program was conducted from 2010 through 2014. The program was divided into two periods: from 2010 to 2012 (pilot study) and from 2013 to 2014. The pilot study consisted of routine HIV testing of patients aged 18–55 that were hospitalized in one department. In the second period, all inpatients aged 18–65 were eligible. Targeted testing was conducted in the other inpatient department during the pilot study and the outpatient department during both periods. RESULTS: During the pilot study, 2203 patients were hospitalized, 1314 (59.6%) were eligible, 954 (72.6%) were tested, and 3 (0.31%) were newly diagnosed HIV-positive. In the second period, 4911 patients were hospitalized, 3727 (75.9%) were eligible, 3303 (88.6%) were tested, and 7 (0.21%) were HIV-positive. In total, 2800 targeted tests were performed, and 4 (0.14%) patients tested positive with newly discovered HIV. All 14 newly diagnosed patients were provided with care. Comparing cumulative groups of routine and targeted testing, the HIV prevalence was 0.23% vs. 0.14% (p = 0.40) and was above the reported cost-effectiveness threshold of 0.1% (p = 0.012). A lower proportion of advanced disease and a higher proportion of heterosexually transmitted infection were found in the routine testing group. CONCLUSION: Routine HIV testing in admissions of infectious diseases is acceptable, feasible, sustainable and clinically effective. Compared to targeted testing, routine testing helped to discover more patients in earlier stages and those with heterosexually transmitted HIV infection. BioMed Central 2019-01-07 /pmc/articles/PMC6322331/ /pubmed/30616558 http://dx.doi.org/10.1186/s12879-018-3661-0 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Matulionytė, Raimonda Žagminas, Kęstutis Balčiūnaitė, Eglė Matulytė, Elžbieta Paulauskienė, Rasutė Bajoriūnienė, Almina Ambrozaitis, Arvydas Routine HIV testing program in the University Infectious Diseases Centre in Lithuania: a four-year analysis |
title | Routine HIV testing program in the University Infectious Diseases Centre in Lithuania: a four-year analysis |
title_full | Routine HIV testing program in the University Infectious Diseases Centre in Lithuania: a four-year analysis |
title_fullStr | Routine HIV testing program in the University Infectious Diseases Centre in Lithuania: a four-year analysis |
title_full_unstemmed | Routine HIV testing program in the University Infectious Diseases Centre in Lithuania: a four-year analysis |
title_short | Routine HIV testing program in the University Infectious Diseases Centre in Lithuania: a four-year analysis |
title_sort | routine hiv testing program in the university infectious diseases centre in lithuania: a four-year analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322331/ https://www.ncbi.nlm.nih.gov/pubmed/30616558 http://dx.doi.org/10.1186/s12879-018-3661-0 |
work_keys_str_mv | AT matulionyteraimonda routinehivtestingprogramintheuniversityinfectiousdiseasescentreinlithuaniaafouryearanalysis AT zagminaskestutis routinehivtestingprogramintheuniversityinfectiousdiseasescentreinlithuaniaafouryearanalysis AT balciunaiteegle routinehivtestingprogramintheuniversityinfectiousdiseasescentreinlithuaniaafouryearanalysis AT matulyteelzbieta routinehivtestingprogramintheuniversityinfectiousdiseasescentreinlithuaniaafouryearanalysis AT paulauskienerasute routinehivtestingprogramintheuniversityinfectiousdiseasescentreinlithuaniaafouryearanalysis AT bajoriunienealmina routinehivtestingprogramintheuniversityinfectiousdiseasescentreinlithuaniaafouryearanalysis AT ambrozaitisarvydas routinehivtestingprogramintheuniversityinfectiousdiseasescentreinlithuaniaafouryearanalysis |